» Articles » PMID: 977646

125I-labeled Human Epidermal Growth Factor. Binding, Internalization, and Degradation in Human Fibroblasts

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 1976 Oct 1
PMID 977646
Citations 274
Authors
Affiliations
Soon will be listed here.
Abstract

125I-labeled human epidermal growth factor (hEGF) binds in a specific and saturable manner to human fibroblasts. At 37 degrees C, the cell-bound 125I-hEGF initially may be recovered in a native form by acid extraction; upon subsequent incubation, the cell-bound 125I-hEGF is degraded very rapidly, with the appearance in the medium of 125I-monoiodotyrosine. At 0 degrees C, cell-bound 125I-hEGF is not degraded but slowly dissociates from the cell. The data are consistent with a mechanism in which 125I-hEGF initially is bound to the cell surface and subsequently is internlized before degradation. The degradation is blocked by inhibitors of metabolic energy production (azide, cyanide, dinitrophenol), some protease inhibitors (Tos-Lys-CH2Cl, benzyl guanidobenzoate), a lysosomotropic agent (chloroquine) various local anesthetics (cocaine, lidocaine, procaine), and ammonium chloride. After the binding and degradation of 125I-hEGF the fibroblasts are no longer able to rebind fresh hormone. The binding capacity of these cells is restored by incubation in a serum-containing medium; this restoration is inhibited by cycloheximide or actinomycin D.

Citing Articles

Therapeutic advances of targeting receptor tyrosine kinases in cancer.

Tomuleasa C, Tigu A, Munteanu R, Moldovan C, Kegyes D, Onaciu A Signal Transduct Target Ther. 2024; 9(1):201.

PMID: 39138146 PMC: 11323831. DOI: 10.1038/s41392-024-01899-w.


EGFR trafficking: effect of dimerization, dynamics, and mutation.

Schultz D, Billadeau D, Jois S Front Oncol. 2023; 13:1258371.

PMID: 37752992 PMC: 10518470. DOI: 10.3389/fonc.2023.1258371.


In Vitro and In Vivo Evaluation of Epidermal Growth Factor (EGF) Loaded Alginate-Hyaluronic Acid (AlgHA) Microbeads System for Wound Healing.

Ali M, Kwak S, Byeon J, Choi H J Funct Biomater. 2023; 14(8).

PMID: 37623648 PMC: 10455903. DOI: 10.3390/jfb14080403.


Preclinical Characterization of the Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5.

Striese F, Neuber C, Grassel S, Arndt C, Ullrich M, Steinbach J Int J Mol Sci. 2023; 24(11).

PMID: 37298374 PMC: 10253363. DOI: 10.3390/ijms24119420.


Mechanisms for Regulating and Organizing Receptor Signaling by Endocytosis.

Von Zastrow M, Sorkin A Annu Rev Biochem. 2021; 90:709-737.

PMID: 33606955 PMC: 8608402. DOI: 10.1146/annurev-biochem-081820-092427.


References
1.
Hunter W, GREENWOOD F . Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962; 194:495-6. DOI: 10.1038/194495a0. View

2.
Seglen P . Protein degradation in isolated rat hepatocytes is inhibited by ammonia. Biochem Biophys Res Commun. 1975; 66(1):44-52. DOI: 10.1016/s0006-291x(75)80292-0. View

3.
DE DUVE C, de Barsy T, Poole B, Trouet A, Tulkens P, Van Hoof F . Commentary. Lysosomotropic agents. Biochem Pharmacol. 1974; 23(18):2495-531. DOI: 10.1016/0006-2952(74)90174-9. View

4.
Lefkowitz R, Roth J, Pastan I . ACTH-receptor interaction in the adrenal: a model for the initial step in the action of hormones that stimulate adenyl cyclase. Ann N Y Acad Sci. 1971; 185:195-209. DOI: 10.1111/j.1749-6632.1971.tb45249.x. View

5.
Dufau M, Catt K, Tsuruhara T . Biological activity of human chorionic gonadotropin released from testis binding-sites. Proc Natl Acad Sci U S A. 1972; 69(9):2414-6. PMC: 426952. DOI: 10.1073/pnas.69.9.2414. View